Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEF

NCT03541603 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension Pulmonary Secondary
Heart Failure, Right Sided
Heart Failure With Normal Ejection Fraction

Interventions

DRUG: Levosimendan
DRUG: Matching Placebo

Sponsor

Tenax Therapeutics, Inc.